PMID: 29484868Feb 28, 2018Paper

GENE THERAPY POTENTIAL AS A TREATMENT FOR HEART FAILURE

Harefuah
Michael G KatzCharles R Bridges

Abstract

Advances in understanding the molecular biology of heart failure, the evolution of vector technology, as well as defining the targets for therapeutic interventions has placed heart failure within the reach of gene-based therapy. During the last decade the concept of delivering cDNA encoding a therapeutic gene to failing cardiomyocytes has moved from hypothesis to the bench of preclinical applications and clinical trials. However, despite significant promise, several obstacles exist, which are described in this review. We anticipate that advances in the field will improve gene therapy in heart failure in future clinical approaches.

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Related Papers

Journal of Cardiovascular Translational Research
Hung LyRoger J Hajjar
The Journal of Clinical Investigation
Roger J Hajjar
Journal of the American College of Cardiology
Yoshiaki KawaseRoger J Hajjar
© 2022 Meta ULC. All rights reserved